Then there are stem cells, which tantalize with their myriad possibilities: allowing diabetics to throw away their insulin, growing healthy
cardiac tissue after a heart attack, restoring function to people with spinal cord injury (for which the Food and Drug Administration just approved the first embryonic stem cell trial).
Not exact matches
Investigators at the Cedars - Sinai Heart Institute — whose previous research showed that
cardiac stem cell therapy reduces scarring and regenerates healthy
tissue after a heart attack in humans — have identified components of those stem cells responsible for the beneficial effects.
Cardiac surgery can cause
tissue injury when blood supply returns
after a period of low oxygen.
Complications
after surgery include relapse of all symptoms,
cardiac arrhythmias, necrosis (death of
tissue) and perforation of damaged organs, and peritonitis (sepsis of the abdominal cavity).